PNC Financial Services Group Inc. increased its stake in LivaNova PLC (NASDAQ:LIVN) by 1.9% during the second quarter, Holdings Channel reports. The firm owned 2,916 shares of the company’s stock after buying an additional 54 shares during the period. PNC Financial Services Group Inc.’s holdings in LivaNova PLC were worth $147,000 at the end of the most recent reporting period.
Other institutional investors also recently added to or reduced their stakes in the company. LS Investment Advisors LLC increased its position in LivaNova PLC by 70.7% in the second quarter. LS Investment Advisors LLC now owns 2,840 shares of the company’s stock valued at $143,000 after buying an additional 1,176 shares during the period. Advisory Services Network LLC increased its stake in LivaNova PLC by 7.8% in the second quarter. Advisory Services Network LLC now owns 3,508 shares of the company’s stock worth $176,000 after buying an additional 253 shares during the last quarter. Capstone Asset Management Co. acquired a new stake in LivaNova PLC during the second quarter worth about $204,000. Quantitative Systematic Strategies LLC acquired a new stake in LivaNova PLC during the second quarter worth about $208,000. Finally, AXA acquired a new stake in LivaNova PLC during the first quarter worth about $291,000. 63.67% of the stock is currently owned by hedge funds and other institutional investors.
Shares of LivaNova PLC (NASDAQ:LIVN) traded down 0.41% during midday trading on Friday, hitting $58.36. 220,319 shares of the stock traded hands. The company’s 50 day moving average price is $60.36 and its 200-day moving average price is $54.20. The stock’s market cap is $2.85 billion. LivaNova PLC has a 12-month low of $46.79 and a 12-month high of $77.00.
A number of research firms recently issued reports on LIVN. Piper Jaffray Cos. reaffirmed an “overweight” rating and set a $59.00 price target (down previously from $61.00) on shares of LivaNova PLC in a research note on Thursday, July 7th. WBB Securities reaffirmed a “hold” rating and set a $60.00 price target on shares of LivaNova PLC in a research note on Wednesday, August 31st. Six equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. LivaNova PLC has an average rating of “Hold” and an average target price of $67.20.
In other news, major shareholder Two S.C.A. Equinox sold 185,000 shares of the firm’s stock in a transaction that occurred on Thursday, September 22nd. The shares were sold at an average price of $61.54, for a total transaction of $11,384,900.00. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Jacques Gutedel sold 4,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 9th. The stock was sold at an average price of $60.52, for a total transaction of $242,080.00. Following the sale, the insider now directly owns 10,948 shares in the company, valued at approximately $662,572.96. The disclosure for this sale can be found here. Insiders own 0.70% of the company’s stock.
LivaNova PLC Company Profile
LivaNova PLC is a medical technology company. The Company operates through three segments: Cardiac Surgery, Cardiac Rhythm Management (CRM) and Neuromodulation. The Cardiac Surgery business unit is engaged in the development, production and sale of cardiovascular surgery products, including oxygenators, heart-lung machines, perfusion tubing systems and systems for autotransfusion and autologous blood washing.
Want to see what other hedge funds are holding LIVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LivaNova PLC (NASDAQ:LIVN).
Receive News & Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related companies with MarketBeat.com's FREE daily email newsletter.